Welcome to episode 15 of The 5-Minute Investor Podcast, where Stockhouse columnists Jonathon Brown and Trevor Abes each deliver a 2.5-minute stock pick related to recent news stories with investment ...

Tilray Medical, a division of Tilray Brands (TSX:TLRY), has become the first company to receive Italian authorization to distribute medical cannabis flower for therapeutic use ...

Cymat Technologies (TSXV:CYM) signed a letter of intent with Rio Tinto Alcan to acquire the latter’s aluminum metal matrix composite technology, including an existing customer base ...

MONTRÉAL, June 23, 2025 (GLOBE NEWSWIRE) -- TC Transcontinental (TSX: TCL.A TCL.B) announced today the acquisition of Middleton Group, a provider of retail services and point-of-purchase display ...

VANCOUVER, BRITISH COLUMBIA – TheNewswire - June 2, 2025 (TSXV: PINN, OTC: NRGOF, Frankfurt: P9J) – Pinnacle Silver and Gold Corp. (" Pinnacle" or the “ Company") is pleased to announce that ...

Aurora Cannabis (TSX:ACB) issued a firm denial of recent misinformation circulating online regarding alleged acquisitions and strategic partnerships ...

Get a summary of what's been happening on the Stockhouse forums on a weekly basis. Article highlights key forums to watch and explore.

Quarter Review and Near-Term Priorities. Production of 195 Mboe / d was up 4% quarter-over-quarter, driven by record production at Cold Lake.Operating earnings of $322 million, also a record, ...

Conference call will be held today, Monday, May 12 at 9:00 am ET. CARMEL, Ind., May 12, 2025 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company&CloseCurlyDoubleQuote ...

Create a free multiple transaction based Portoflio of all of your investments including stocks, funds, and cash. Track gains and losses over time by tracking every buy and sell transaction.

CAESAREA, Israel, May 28, 2025 /PRNewswire/ -- IceCure Medical Ltd. (NASDAQ: ICCM) ("IceCure", "IceCure Medical" or the "Company"), developer of minimally-invasive cryoablation technology that ...

MediPharm Labs (TSX:LABS) has begun production for its novel cannabis metered dose inhalers (MDIs) tailored for the EU and UK markets.